نتایج جستجو برای: blocker therapy

تعداد نتایج: 668728  

Journal: :Hinyokika kiyo. Acta urologica Japonica 2012
Tatsuya Takayama Ichiro Arakawa Hiroaki Kakihara Keijiro Tachibana Seiichiro Ozono

The cost-effectiveness of combination therapy with an α1 blocker and dutasteride in benign prostatic hyperplasia (BPH) was analyzed in comparison with α1 blocker monotherapy. A Markov model with seven health states related to BPH was constructed with 4-year and 10-year time horizons and from the entire payers perspective. The transition probabilities among different health states input into the...

2017
Jaehoon Chung Jung‐Kyu Han Young Jo Kim Chong Jin Kim Youngkeun Ahn Myeong Chan Cho Shung Chull Chae In‐Ho Chae Jei Keon Chae In‐Whan Seong Han‐Mo Yang Kyung‐Woo Park Hyun‐Jae Kang Bon‐Kwon Koo Myung Ho Jeong Hyo‐Soo Kim Tae Hoon Ahn Kwang Soo Cha Hyeon‐Cheol Gwon Jin‐Yong Hwang Seung Jae Joo Doo‐il Kim Kwon‐Bae Kim Dong Joo Oh Seok Kyu Oh Ki‐Bae Seung Jung‐Han Yoon

BACKGROUND Although current guidelines recommend β-blocker after acute myocardial infarction (MI), the role of β-blocker has not been well investigated in the modern reperfusion era. In particular, the benefit of vasodilating β-blocker over conventional β-blocker is still unexplored. METHODS AND RESULTS Using nation-wide multicenter Korean Acute Myocardial Infarction Registry data, we analyze...

Journal: :Circulation 2006
Stefan H Hohnloser Paul Dorian Robin Roberts Michael Gent Carsten W Israel Eric Fain Jean Champagne Stuart J Connolly

BACKGROUND Many patients with implanted cardioverter defibrillators (ICDs) receive adjunctive antiarrhythmic drug therapy, most commonly amiodarone or sotalol. The effects of these drugs on defibrillation energy requirements have not been previously assessed in a randomized controlled trial. METHODS AND RESULTS The Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC)...

Journal: :European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 2011
Shinji Inaba Hideki Okayama Haruhiko Higashi Kazuhisa Nishimura Katsuji Inoue Akiyoshi Ogimoto Jitsuo Higaki

Myocardial bridging (MB) is a congenital anomaly characterized by systolic compression of the tunnelled arterial segment. MB may cause myocardial ischaemia due to abnormal coronary blood flow. We report a case of MB in which transthoracic Doppler echocardiography was used to evaluate the long-term effect of beta-blocker therapy on abnormal coronary blood flow. In this case, beta-blocker therapy...

Journal: :JACC. Cardiovascular interventions 2014
Christopher B Granger Meena P Rao

Randomized clinical trials have conclusively shown that beta-blocker therapy reduces mortality by about 20% during the 2-year period following myocardial infarction (MI) (1–3). On the basis of these data, international guidelines recommend beta-blocker therapy as a class 1 recommendation for patients who have MI, including ST-segment elevation myocardial infarction (STEMI), initiated within the...

Journal: :Circulation 2009
J Kevin Donahue

For patients with reduced ejection fraction (EF), the risk of cardiac arrest is particularly high in the healing phase immediately after a myocardial infarction (MI). Estimates from recent clinical trials show an annualized sudden-death risk of 8% to 12% in the 3-month period after MI, even with optimal medical therapy including appropriate revascularization, -adrenergic receptor blocker, aldos...

2015
C Fuchs C Scheer S Wauschkuhn M Vollmer S Rehberg K Meissner SO Kuhn S Friesecke P Abel M Gründling

Introduction A continuous infusion of the beta-blocker esmolol has recently been demonstrated to increase stroke volume without increasing norepinephrine dosage or impairing microcirculation in patients with septic shock [1]. In addition, a pre-existing oral therapy with beta-blockers was associated with a potential 28-day mortality survival benefit in septic patients [2]. The influence of a ne...

Journal: :Cardiology journal 2017
Jinggang Xia Yang Qu Chunlin Yin Dong Xu

BACKGROUND This study aimed to evaluate the role of b-blocker therapy on modulating interleukin (IL)-33/ST2 (interleukin-1 receptor-like 1) signaling during ventricular remodeling related to heart failure (HF) after acute myocardial infarction (AMI). METHODS Sprague-Dawley rats that survived surgery to induce AMI were randomly divided into the placebo group and the b-blocker treatment group. ...

Journal: :Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2005
David Tingey Lisa M Bernard Daniel T Grima Betsy Miller Annette Lam

BACKGROUND The purpose of this study was to characterize current patterns of treatment of glaucoma and ocular hypertension and to examine the effect of those patterns on intraocular pressure (IOP) control and persistence on therapy. METHODS A retrospective chart review was conducted at 3 ophthalmology practices in Alberta. Data were collected for patients who had begun therapy for newly diagn...

Journal: :Journal of managed care pharmacy : JMCP 2009
Kristie L Ramser Laura R Sprabery Gale L Hamann Christa M George Aaron Will

BACKGROUND In July 2005, the State of Tennessee Medicaid Program (TennCare) announced formulary changes for proton pump inhibitors (PPIs) to be implemented in August 2005. Prior to these changes, pantoprazole was the only preferred PPI, and there were no restrictions to its use. The revised formulary included 3 preferred PPIs (esomeprazole, lansoprazole, and omeprazole OTC), all of which requir...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید